ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alpha-1 Antitrypsin Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-26I8550
Home | Market Reports | Health| Pharmacy
Global Alpha 1 Antitrypsin Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Alpha-1 Antitrypsin Drugs Market Research Report 2025

Code: QYRE-Auto-26I8550
Report
August 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
CSL Behring
Grifols S A
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta

Alpha-1 Antitrypsin Drugs Market Size

The global market for Alpha-1 Antitrypsin Drugs was valued at US$ 1434 million in the year 2024 and is projected to reach a revised size of US$ 2502 million by 2031, growing at a CAGR of 8.4% during the forecast period.

Alpha-1 Antitrypsin Drugs Market

Alpha-1 Antitrypsin Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alpha-1 Antitrypsin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-1 Antitrypsin Drugs.
The Alpha-1 Antitrypsin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha-1 Antitrypsin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-1 Antitrypsin Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alpha-1 Antitrypsin Drugs Market Report

Report Metric Details
Report Name Alpha-1 Antitrypsin Drugs Market
Accounted market size in year US$ 1434 million
Forecasted market size in 2031 US$ 2502 million
CAGR 8.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Parenteral
  • Inhalation
Segment by Application
  • Drugstore
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, CSL Behring, Grifols, Kamada, Abeona Therapeutics, Alnylam Pharmaceuticals, Applied Genetic Technologies Corp, Arrowhead Research Corporation, Baxalta
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Alpha-1 Antitrypsin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Alpha-1 Antitrypsin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Alpha-1 Antitrypsin Drugs Market growing?

Ans: The Alpha-1 Antitrypsin Drugs Market witnessing a CAGR of 8.4% during the forecast period 2025-2031.

What is the Alpha-1 Antitrypsin Drugs Market size in 2031?

Ans: The Alpha-1 Antitrypsin Drugs Market size in 2031 will be US$ 2502 million.

Who are the main players in the Alpha-1 Antitrypsin Drugs Market report?

Ans: The main players in the Alpha-1 Antitrypsin Drugs Market are Baxter, CSL Behring, Grifols, Kamada, Abeona Therapeutics, Alnylam Pharmaceuticals, Applied Genetic Technologies Corp, Arrowhead Research Corporation, Baxalta

What are the Application segmentation covered in the Alpha-1 Antitrypsin Drugs Market report?

Ans: The Applications covered in the Alpha-1 Antitrypsin Drugs Market report are Drugstore, Hospital, Others

What are the Type segmentation covered in the Alpha-1 Antitrypsin Drugs Market report?

Ans: The Types covered in the Alpha-1 Antitrypsin Drugs Market report are Parenteral, Inhalation

1 Alpha-1 Antitrypsin Drugs Market Overview
1.1 Product Definition
1.2 Alpha-1 Antitrypsin Drugs by Type
1.2.1 Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Parenteral
1.2.3 Inhalation
1.3 Alpha-1 Antitrypsin Drugs by Application
1.3.1 Global Alpha-1 Antitrypsin Drugs Market Value by Application (2024 VS 2031)
1.3.2 Drugstore
1.3.3 Hospital
1.3.4 Others
1.4 Global Alpha-1 Antitrypsin Drugs Market Size Estimates and Forecasts
1.4.1 Global Alpha-1 Antitrypsin Drugs Revenue 2020-2031
1.4.2 Global Alpha-1 Antitrypsin Drugs Sales 2020-2031
1.4.3 Global Alpha-1 Antitrypsin Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Alpha-1 Antitrypsin Drugs Market Competition by Manufacturers
2.1 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Alpha-1 Antitrypsin Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Alpha-1 Antitrypsin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Product Type & Application
2.7 Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Date of Enter into This Industry
2.8 Global Alpha-1 Antitrypsin Drugs Market Competitive Situation and Trends
2.8.1 Global Alpha-1 Antitrypsin Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Alpha-1 Antitrypsin Drugs Players Market Share by Revenue
2.8.3 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alpha-1 Antitrypsin Drugs Market Scenario by Region
3.1 Global Alpha-1 Antitrypsin Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Alpha-1 Antitrypsin Drugs Sales by Region: 2020-2031
3.2.1 Global Alpha-1 Antitrypsin Drugs Sales by Region: 2020-2025
3.2.2 Global Alpha-1 Antitrypsin Drugs Sales by Region: 2026-2031
3.3 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2020-2031
3.3.1 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2020-2025
3.3.2 Global Alpha-1 Antitrypsin Drugs Revenue by Region: 2026-2031
3.4 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.4.1 North America Alpha-1 Antitrypsin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Alpha-1 Antitrypsin Drugs Sales by Country (2020-2031)
3.4.3 North America Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.5.1 Europe Alpha-1 Antitrypsin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Alpha-1 Antitrypsin Drugs Sales by Country (2020-2031)
3.5.3 Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.7.1 Latin America Alpha-1 Antitrypsin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2020-2031)
3.7.3 Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2020-2031)
4.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2020-2025)
4.1.2 Global Alpha-1 Antitrypsin Drugs Sales by Type (2026-2031)
4.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2020-2031)
4.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2020-2031)
4.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2020-2025)
4.2.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2026-2031)
4.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Alpha-1 Antitrypsin Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2020-2031)
5.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2020-2025)
5.1.2 Global Alpha-1 Antitrypsin Drugs Sales by Application (2026-2031)
5.1.3 Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2020-2031)
5.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2020-2031)
5.2.1 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2020-2025)
5.2.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2026-2031)
5.2.3 Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Alpha-1 Antitrypsin Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter Alpha-1 Antitrypsin Drugs Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Company Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Alpha-1 Antitrypsin Drugs Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Kamada
6.4.1 Kamada Company Information
6.4.2 Kamada Description and Business Overview
6.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kamada Alpha-1 Antitrypsin Drugs Product Portfolio
6.4.5 Kamada Recent Developments/Updates
6.5 Abeona Therapeutics
6.5.1 Abeona Therapeutics Company Information
6.5.2 Abeona Therapeutics Description and Business Overview
6.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product Portfolio
6.5.5 Abeona Therapeutics Recent Developments/Updates
6.6 Alnylam Pharmaceuticals
6.6.1 Alnylam Pharmaceuticals Company Information
6.6.2 Alnylam Pharmaceuticals Description and Business Overview
6.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product Portfolio
6.6.5 Alnylam Pharmaceuticals Recent Developments/Updates
6.7 Applied Genetic Technologies Corp
6.7.1 Applied Genetic Technologies Corp Company Information
6.7.2 Applied Genetic Technologies Corp Description and Business Overview
6.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product Portfolio
6.7.5 Applied Genetic Technologies Corp Recent Developments/Updates
6.8 Arrowhead Research Corporation
6.8.1 Arrowhead Research Corporation Company Information
6.8.2 Arrowhead Research Corporation Description and Business Overview
6.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product Portfolio
6.8.5 Arrowhead Research Corporation Recent Developments/Updates
6.9 Baxalta
6.9.1 Baxalta Company Information
6.9.2 Baxalta Description and Business Overview
6.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Baxalta Alpha-1 Antitrypsin Drugs Product Portfolio
6.9.5 Baxalta Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alpha-1 Antitrypsin Drugs Industry Chain Analysis
7.2 Alpha-1 Antitrypsin Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alpha-1 Antitrypsin Drugs Production Mode & Process Analysis
7.4 Alpha-1 Antitrypsin Drugs Sales and Marketing
7.4.1 Alpha-1 Antitrypsin Drugs Sales Channels
7.4.2 Alpha-1 Antitrypsin Drugs Distributors
7.5 Alpha-1 Antitrypsin Drugs Customer Analysis
8 Alpha-1 Antitrypsin Drugs Market Dynamics
8.1 Alpha-1 Antitrypsin Drugs Industry Trends
8.2 Alpha-1 Antitrypsin Drugs Market Drivers
8.3 Alpha-1 Antitrypsin Drugs Market Challenges
8.4 Alpha-1 Antitrypsin Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Baxter
CSL Behring
Grifols S A
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
List of Tables
 Table 1. Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Alpha-1 Antitrypsin Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Alpha-1 Antitrypsin Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Alpha-1 Antitrypsin Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Alpha-1 Antitrypsin Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Alpha-1 Antitrypsin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Alpha-1 Antitrypsin Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alpha-1 Antitrypsin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Alpha-1 Antitrypsin Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Alpha-1 Antitrypsin Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Alpha-1 Antitrypsin Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Alpha-1 Antitrypsin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Alpha-1 Antitrypsin Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Alpha-1 Antitrypsin Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Alpha-1 Antitrypsin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Alpha-1 Antitrypsin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Alpha-1 Antitrypsin Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Alpha-1 Antitrypsin Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Baxter Company Information
 Table 71. Baxter Description and Business Overview
 Table 72. Baxter Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Baxter Alpha-1 Antitrypsin Drugs Product
 Table 74. Baxter Recent Developments/Updates
 Table 75. CSL Behring Company Information
 Table 76. CSL Behring Description and Business Overview
 Table 77. CSL Behring Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Behring Alpha-1 Antitrypsin Drugs Product
 Table 79. CSL Behring Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Grifols Alpha-1 Antitrypsin Drugs Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Kamada Company Information
 Table 86. Kamada Description and Business Overview
 Table 87. Kamada Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Kamada Alpha-1 Antitrypsin Drugs Product
 Table 89. Kamada Recent Developments/Updates
 Table 90. Abeona Therapeutics Company Information
 Table 91. Abeona Therapeutics Description and Business Overview
 Table 92. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Product
 Table 94. Abeona Therapeutics Recent Developments/Updates
 Table 95. Alnylam Pharmaceuticals Company Information
 Table 96. Alnylam Pharmaceuticals Description and Business Overview
 Table 97. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Product
 Table 99. Alnylam Pharmaceuticals Recent Developments/Updates
 Table 100. Applied Genetic Technologies Corp Company Information
 Table 101. Applied Genetic Technologies Corp Description and Business Overview
 Table 102. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Product
 Table 104. Applied Genetic Technologies Corp Recent Developments/Updates
 Table 105. Arrowhead Research Corporation Company Information
 Table 106. Arrowhead Research Corporation Description and Business Overview
 Table 107. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Product
 Table 109. Arrowhead Research Corporation Recent Developments/Updates
 Table 110. Baxalta Company Information
 Table 111. Baxalta Description and Business Overview
 Table 112. Baxalta Alpha-1 Antitrypsin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Baxalta Alpha-1 Antitrypsin Drugs Product
 Table 114. Baxalta Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Alpha-1 Antitrypsin Drugs Distributors List
 Table 118. Alpha-1 Antitrypsin Drugs Customers List
 Table 119. Alpha-1 Antitrypsin Drugs Market Trends
 Table 120. Alpha-1 Antitrypsin Drugs Market Drivers
 Table 121. Alpha-1 Antitrypsin Drugs Market Challenges
 Table 122. Alpha-1 Antitrypsin Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alpha-1 Antitrypsin Drugs
 Figure 2. Global Alpha-1 Antitrypsin Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Alpha-1 Antitrypsin Drugs Market Share by Type: 2024 & 2031
 Figure 4. Parenteral Product Picture
 Figure 5. Inhalation Product Picture
 Figure 6. Global Alpha-1 Antitrypsin Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Alpha-1 Antitrypsin Drugs Market Share by Application: 2024 & 2031
 Figure 8. Drugstore
 Figure 9. Hospital
 Figure 10. Others
 Figure 11. Global Alpha-1 Antitrypsin Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Alpha-1 Antitrypsin Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Alpha-1 Antitrypsin Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Alpha-1 Antitrypsin Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 15. Alpha-1 Antitrypsin Drugs Report Years Considered
 Figure 16. Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Alpha-1 Antitrypsin Drugs Players: Market Share by Revenue in Alpha-1 Antitrypsin Drugs in 2024
 Figure 19. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Alpha-1 Antitrypsin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Alpha-1 Antitrypsin Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Alpha-1 Antitrypsin Drugs by Type (2020-2031)
 Figure 56. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Alpha-1 Antitrypsin Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Alpha-1 Antitrypsin Drugs by Application (2020-2031)
 Figure 59. Global Alpha-1 Antitrypsin Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 60. Alpha-1 Antitrypsin Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions